Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001905390 | SCV002133982 | uncertain significance | MHC class II deficiency | 2021-07-04 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CIITA-related conditions. This sequence change replaces leucine with valine at codon 171 of the CIITA protein (p.Leu171Val). The leucine residue is weakly conserved and there is a small physicochemical difference between leucine and valine. |